A purple and pink letter v on a white background.
May 22, 2026

Skin Cancer Awareness Month Guide for Dermatologists

May marks Skin Cancer Awareness Month, a time dedicated to spreading vital information about prevention, detection, and treatment of skin cancer. With more than 6 million diagnoses each year in the United States alone, skin cancer is the most common cancer. 

 

Early detection is crucial, and as dermatologists, you play a pivotal role in identifying the signs early, offering treatments, and guiding your patients through preventative measures. Understanding skin cancer's various forms and the latest technology in treatment is essential for providing the best care to your patients. 

 

The Growing Risk of Skin Cancer


Skin cancer is a rapidly growing health concern across the globe. Basal cell carcinoma and squamous cell carcinoma, two types of non-melanoma skin cancers, are the most commonly diagnosed. These cancers are typically less aggressive and rarely spread to other parts of the body. However, melanoma, a more aggressive form of skin cancer, poses significant risks. 

 

Melanoma is known to spread rapidly and can be fatal if not caught early. It is primarily found in fair-skinned individuals, with exposure to ultraviolet (UV) radiation being a key risk factor. Prolonged exposure to both natural sunlight and artificial sunlight, such as from tanning beds, can increase the chances of developing melanoma. 

 

The Role of Early Detection 


Early detection of skin cancer can significantly improve outcomes. Dermatologists must educate their patients about how to spot warning signs of skin cancer, such as unusual moles or skin changes. The Skin Cancer Foundation promotes the ABCDE rule, which encourages individuals to examine moles for asymmetry, irregular borders, multiple colors, diameter, and evolution over time. Dermatologists should also perform full-body skin examinations during routine visits, looking for any abnormalities in existing moles or new skin growths. 

 

Prevention and Protection 


Preventing skin cancer involves consistent and effective skin protection strategies. Education on the use of broad-spectrum sunscreen is key. Dermatologists can educate patients about the importance of reapplying sunscreen every two hours, especially after sweating or swimming. Additionally, wearing protective clothing, sunglasses, and hats, and avoiding direct sun exposure during peak hours, can help reduce risk. Tanning beds should also be discouraged as they expose the skin to harmful UV radiation. 

 

During Skin Cancer Awareness Month, sharing these protective habits through various media channels can help raise awareness about the importance of skin health. Dermatologists should encourage their patients to stay informed about the risks associated with prolonged sun exposure and remind them of the simple ways to protect themselves. 

 

The Importance of Skin Cancer Education 


As part of Skin Cancer Awareness Month, dermatologists should strive to actively educate their communities. Whether through workshops, webinars, or social media campaigns, spreading awareness about skin cancer prevention and early detection can save lives. Utilizing digital platforms allows dermatologists to reach a broader audience, educating them on the importance of regular skin checks and encouraging them to take action if they notice any concerning changes. 

 

Additionally, skin cancer awareness initiatives can include promoting skin checks, where patients examine their skin regularly and report any changes to their healthcare provider. This simple action can lead to early detection and better treatment outcomes. 

 

Advocacy for Skin Cancer Research 


Skin Cancer Awareness Month is also a time to support ongoing research aimed at better understanding and treating skin cancer. With continued investment in research and new treatment methods, there is hope for better, more effective therapies for patients battling skin cancer. Collaborating with research institutions and staying updated on the latest breakthroughs in treatment options can help dermatologists remain at the forefront of their field. 

 

Closing Thoughts on Skin Cancer Awareness Month 


As a dermatologist, your role in preventing and treating skin cancer is vital. Skin Cancer Awareness Month serves as an opportunity to reflect on the progress made and the work that is still ahead. It is a time to give patients the knowledge they need to protect their skin, and it is a time for professionals to ensure that they are equipped with the best tools for diagnosis and treatment. With the right equipment and education, we can make strides in reducing the incidence of skin cancer and improving patient outcomes. 

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.